Identification and validation of γ-Linolenic acid as a natural FABP5 inhibitor in hepatocellular carcinoma through deep learning and experimental approaches

Key Points

• Identification of γ-linolenic acid reveals its role as a natural FABP5 inhibitor, important for treating hepatocellular carcinoma.
• Deep learning analysis highlights γ-linolenic acid's potential, acting as an innovative compound against liver cancer.
• Experimental approaches confirm the inhibitory effect of γ-linolenic acid on FABP5, supporting its therapeutic use.
• The findings advocate for further exploration of γ-linolenic acid in liver cancer treatments, indicating possible clinical applications.

Abstract